Citations

Mayo Clinic

Showing 10 of 108551 citations.

High Resting Coronary Flow Velocity by Echocardiography Is Associated With Worse Survival in Patients With Chronic Coronary Syndromes
Cortigiani, Lauro , Gaibazzi, Nicola , Ciampi, Quirino , Rigo, F , Rodríguez‐Zanella, Hugo , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Arbucci, Rosina , Lowenstein, Jorge , Zagatina, A , Bartolacelli, Ylenia , Picano, Eugenio , group, the Stress Echo 2030 study, Rigo, Fausto , Zagatina, Angela , Gregori, Dario , Carerj, Scipione , Pepi, Mauro , Pellikka, Patricia A , Picano, Eugenio , Ciampi, Quirino , Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Gaibazzi, Nicola , Arbucci, Rosina , Rodriguez-Zanella, Hugo , Pellikka, Patricia A. , group, the Stress Echo 2030 study

Journal of the American Heart Association | February 16, 2024 | Volume: 13 | Issue: 4 | Pages: No page available

10.1161/jaha.123.031270 | PMID 38362899 Get It

Background Resting coronary flow velocity (CFV) in the mid‐distal left anterior descending coronary artery can be easily assessed with transthoracic echocardiography. In this observational study, the authors sought to assess the relationship between resting CFV, CFV reserve (CFVR), and outcome in patients with chronic coronary syndromes. Methods and Results In a prospective multicenter study design, the authors retrospectively analyzed 7576 patients (age, 66±11 years; 4312 men) with chronic coronary syndromes and left ventricular ejection fraction ≥50% referred for dipyridamole stress echocardiography. Recruitment (years 2003–2021) involved 7 accredited laboratories, with interobserver variability <10% for CFV measurement at study entry. Baseline peak diastolic CFV was obtained by pulsed‐wave Doppler in the mid‐distal left anterior descending coronary artery. CFVR (abnormal value ≤2.0) was assessed with dipyridamole. All‐cause death was the only end point. The mean CFV of the left anterior descending coronary artery was 31±12 cm/s. The mean CFVR was 2.32±0.60. During a median follow‐up of 5.9±4.3 years, 1121 (15%) patients died. At multivariable analysis, resting CFV ≥32 cm/s was identified by a receiver operating curve as the best cutoff and was independently associated with mortality (hazard ratio [HR], 1.24 [95% CI, 1.10–1.40]; P <0.0001) together with CFVR ≤2.0 (HR, 1.78 [95% CI, 1.57–2.02]; P <0.0001), age, diabetes, history of coronary surgery, and left ventricular ejection fraction. When both CFV and CFVR were considered, the mortality rate was highest in patients with resting CFV ≥32 cm/s and CFVR ≤2.0 and lowest in patients with resting CFV <32 cm/s and CFVR >2.0. Conclusions High resting CFV is associated with worse survival in patients with chronic coronary syndromes and left ventricular ejection fraction ≥50%. The value is independent and additive to CFVR. The combination of high resting CFV and low CFVR is associated with the worst survival.
Sorbs2 Deficiency and Vascular BK Channelopathy in Diabetes
Sun, Xiaojing , Lee, Hon-Chi , Lü, Tong , Lu, Tong

Circulation Research | February 16, 2024 | Volume: 134 | Issue: 7 | Pages: 858-871

10.1161/circresaha.123.323538 | PMID 38362769 Get It

BACKGROUND: Vascular large conductance Ca 2+ -activated K + (BK) channel, composed of the α-subunit (BK-α) and the β1-subunit (BK-β1), is a key determinant of coronary vasorelaxation and its function is impaired in diabetic vessels. However, our knowledge of diabetic BK channel dysregulation is incomplete. The Sorbs2 (Sorbin homology [SoHo] and Src homology 3 [SH3] domains-containing protein 2), is ubiquitously expressed in arteries, but its role in vascular pathophysiology is unknown. METHODS: The role of Sorbs2 in regulating vascular BK channel activity was determined using patch-clamp recordings, molecular biological techniques, and in silico analysis. RESULTS: Sorbs2 is not only a cytoskeletal protein but also an RNA-binding protein that binds to BK channel proteins and BK-α mRNA, regulating BK channel expression and function in coronary smooth muscle cells. Molecular biological studies reveal that the SH3 domain of Sorbs2 is necessary for Sorbs2 interaction with BK-α subunits, while both the SH3 and SoHo domains of Sorbs2 interact with BK-β1 subunits. Deletion of the SH3 or SoHo domains abolishes the Sorbs2 effect on the BK-α/BK-β1 channel current density. Additionally, Sorbs2 is a target gene of the Nrf2 (nuclear factor erythroid-2-related factor 2), which binds to the promoter of Sorbs2 and regulates Sorbs2 expression in coronary smooth muscle cells. In vivo studies demonstrate that Sorbs2 knockout mice at 4 months of age display a significant decrease in BK channel expression and function, accompanied by impaired BK channel Ca 2+ -sensitivity and BK channel-mediated vasodilation in coronary arteries, without altering their body weights and blood glucose levels. Importantly, Sorbs2 expression is significantly downregulated in the coronary arteries of db/db type 2 diabetic mice. CONCLUSIONS: Sorbs2, a downstream target of Nrf2, plays an important role in regulating BK channel expression and function in vascular smooth muscle cells. Vascular Sorbs2 is downregulated in diabetes. Genetic knockout of Sorbs2 manifests coronary BK channelopathy and vasculopathy observed in diabetic mice, independent of obesity and glucotoxicity.
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma
Abou‐Alfa, Ghassan K. , Geyer, Susan M. , Nixon, Andrew B. , Innocenti, Federico , Shi, Qian , Kumthekar, Priya , Jacobson, Sawyer , Dika, Imane El , Yaqubie, Amin , Lopez, Juan , Huang, Binhui , Wen, Yujia , Knox, Jennifer J. , Rajdev, Lakshmi , Meyerhardt, Jeffrey A. , El Dika, Imane , Tang, Yi-Wei , Wen, Yujia , Schwartz, Lawrence H , El-Khouiery, Anthony B , Knox, Jennifer J , Rajdev, Lakshmi , Bertagnolli, Monica M , Meyerhardt, Jeffrey A , O'Reilly, Eileen M , Venook, Alan P , Shi, Qian , Abou-Alfa, Ghassan K , Nixon, Andrew B , Tang, Yi‐Wei , Schwartz, Lawrence H. , El-Khoueiry, Anthony B. , Bertagnolli, Monica M. , O’Reilly, Eileen M. , Venook, Alan P.

Cancer Research Communications | February 16, 2024 | Volume: 4 | Issue: 3 | Pages: 682-690

10.1158/2767-9764.crc-22-0516 | PMID 38363156 Get It

Abstract Sorafenib blocks nonstructural protein 5A (NS5A)-recruited c-Raf–mediated hepatitis C virus (HCV) replication and gene expression. Release of Raf-1-Ask-1 dimer and inhibition of Raf-1 via sorafenib putatively differ in the presence or absence of doxorubicin. Cancer and Leukemia Group B (CALGB) 80802 (Alliance) randomized phase III trial of doxorubicin plus sorafenib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC), showed no improvement in median overall survival (OS). Whether HCV viral load impacts therapy and whether any correlation between HCV titers and outcome based on HCV was studied. In patients with HCV, HCV titer levels were evaluated at baseline and at multiple postbaseline timepoints until disease progression or treatment discontinuation. HCV titer levels were evaluated in relation to OS and progression-free survival (PFS). Among 53 patients with baseline HCV data, 12 patients had undetectable HCV (HCV-UN). Postbaseline HCV titer levels did not significantly differ between treatment arms. One patient in each arm went from detectable to HCV-UN with greater than 2 log-fold titer levels reduction. Aside from these 2 HCV-UN patients, HCV titers remained stable on treatment. Patients who had HCV-UN at baseline were 3.5 times more likely to progress and/or die from HCC compared with HCV detectable (HR = 3.51; 95% confidence interval: 1.58–7.78; P = 0.002). HCV titer levels remained unchanged, negating any sorafenib impact onto HCV titer levels. Although an overall negative phase III study, patients treated with doxorubicin plus sorafenib and sorafenib only, on CALGB 80802 had worse PFS if HCV-UN. Higher levels of HCV titers at baseline were associated with significantly improved PFS. Significance: Sorafenib therapy for HCC may impact HCV replication and viral gene expression. In HCV-positive patients accrued to CLAGB 80802 phase III study evaluating the addition of doxorubicin to sorafenib, HCV titer levels were evaluated at baseline and different timepoints. Sorafenib did not impact HCV titer levels. Despite an improved PFS in patients with detectable higher level HCV titers at baseline, no difference in OS was noted.
Psychodid flies and their implicated role in human myiasis and pseudomyiasis
Mathison, Blaine A. , Madriz, Isaí, Pritt, Bobbi S. , Curler, Gregory R. , Curler, Gregory , Pritt, Bobbi S , Mathison, Blaine A

Journal of Clinical Microbiology | February 16, 2024 | Volume: 62 | Issue: 3 | Pages: No page available

10.1128/jcm.01200-23 | PMID 38363141 Get It

ABSTRACT Several psychodid flies are commonly associated with human-inhabited environments and have been increasingly implicated in cases of human myiasis. However, the basic biology of psychodid larvae is not well-suited for survival in the human intestinal or urogenital tract, making true, prolonged myiasis unlikely. In this review, we performed a systematic literature review of published cases of purported myiasis caused by psychodid flies, their identification, associated clinical findings, and treatment. We also discuss the anatomy and lifecycle of psychodid flies in relation to their purported ability to use human tissue as a nutritive source and survive in the human alimentary or urogenital tracts. Based on the range of non-specific and varied reported clinical manifestations, lack of observed collections, life cycle patterns of psychodid flies, the mechanics of their mouthparts, and breathing requirements, we conclude that most cases likely represent incidental findings, or in rare cases possibly pseudomyiasis, rather than true myiasis, and provide recommendations for clinical evaluation and reporting so that disease misclassification and unnecessary therapy do not occur.
Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy
Louissaint, Jeremy , Vargas, Hugo E. , Vargas, Hugo E

American Journal of Gastroenterology | February 16, 2024 | Volume: 119 | Issue: 5 | Pages: 801-802

10.14309/ajg.0000000000002659 | PMID 38363066 Get It

A qualitative focus group analysis: Increasing fieldwork capacity in genetic counseling training programs
Jirik, Rebecca , Redlinger‐Grosse, Krista , Davis, Claire Rebecca , Nusbaum, Rachel , Reiser, Catherine A. , Berninger, Taylor , Jirik, Rebecca

Journal of Genetic Counseling | February 16, 2024 | Volume: 33 | Issue: 1 | Pages: 71-85

10.1002/jgc4.1847 | PMID 38361377 Get It

AbstractGenetic counselors are an integral part of the healthcare system; however, the number of genetic counselors in many parts of the United States is limited, impacting access to comprehensive healthcare for all patients. One solution to addressing this deficit includes modifying genetic counseling training programs to increase student enrollment. Fieldwork capacity, driven by a limited number of rotation sites and supervisors, produces a significant bottleneck to entering the profession. Other professions have reported on techniques to increase fieldwork capacity; however, the practicality of these techniques for genetic counseling training has yet to be explored. This study seeks to investigate the perspectives of key stakeholders in genetic counseling training programs on the practicality of techniques already posited in the literature from other allied health professions. Semi‐structured focus group interviews with 25 participants were conducted at the 2019 National Society of Genetic Counselors conference. Participants included program directors and supervisors from clinical, industry, and laboratory backgrounds. The focus group responses were analyzed using directed content analysis and a split coding technique, after which several themes emerged within the larger domains of rotation structures, systems infrastructure, skill‐building methods, and other novel techniques to increase fieldwork capacity. Emerging themes included the importance of finding quality student placements rather than maximizing the quantity of participatory cases; a need for transparency about the transferability of skills learned from novel experiences; scaffolding student entrustment to expand supervisor capacity; and recognizing nuances in implementation for individual programs. Overall, the results emphasize the importance of openness in communication to manage expectations for students and supervisors, who may be more hesitant to try novel rotation placements and skill‐building techniques. Genetic counseling programs may use these results to address the bottleneck of fieldwork capacity, increasing student enrollment.
Leptin‐Melanocortin pathway variants and gastric emptying in patients with obesity
Cifuentes, Lizeth , Bublitz, Joshua T., Acosta, Andrés , Hurtado, Maria Daniela , Acosta, Andres , Ghusn, Wissam , Campos, Alejandro , Hurtado, Maria D. , Olson, Janet E.

Neurogastroenterology & Motility | February 16, 2024 | Volume: 36 | Issue: 5 | Pages: No page available

10.1111/nmo.14764 | PMID 38361111 Get It

AbstractBackgroundAccelerated gastric emptying (GE) is a trait seen in obesity. Mutations in the hypothalamic leptin‐melanocortin 4 receptor (Leptin‐MC4R) pathway have been associated with obesity. We sought to investigate the association of leptin‐MC4R pathway variants and GE in patients with obesity.MethodsThis is a cross‐sectional study of patients with a history of severe obesity that were genotyped and completed a GE test by scintigraphy. We evaluated the percentage of GE (GE %) at 2 and 4 h between both groups using ANCOVA with weight and sex as covariates. We subdivide patients into carriers based on the location of the identified variants (i.e., upstream or downstream of the Leptin‐MC4R pathway) and compared them with noncarriers using ANOVA. Results are presented as mean and standard deviation (± SD).Key ResultsA total of 95 patients; nine carriers (67% females; 39.78 ± 12.33 years; BMI: 49.14 ± 12.96 kg/m2) and 86 noncarriers (87% female; 49.98 ± 13.74 years; BMI: 40.75 ± 6.29 kg/m2) were included. At 2 and 4 h, carriers had a delayed GE when compared noncarriers (p = 0.03 and p = 0.005, respectively). In carriers, when compared upstream carriers vs. downstream carriers vs. noncarriers by location there was a significant difference in GE among groups at 2 h and at 4 h (p = 0.02 and p = 0.01, respectively).Conclusions & InferencesCarriers of heterozygous variants in the Leptin‐MC4R pathway had a delayed GE compared to noncarriers. These findings point the important relationship between the Leptin‐MC4R pathway and gastric motility.
Cardiac implantable electronic devices in female patients: Esthetic, breast implant, and anatomic considerations
Salinas, Cristina A., Mulpuru, Siva K. , Asirvatham, Samuel J. , Sharaf, Basel , Ezzeddine, Fatima , Mulpuru, Siva K , Asirvatham, Samuel J , Sharaf, Basel A, Sharaf, Basel A , Ezzeddine, Fatima M.

Journal of Cardiovascular Electrophysiology | February 15, 2024 | Volume: 35 | Issue: 4 | Pages: 747-761

10.1111/jce.16196 | PMID 38361241 Get It

Abstract Introduction The implantation of a cardiac implantable electronic device (CIED) can have esthetic and psychological consequences on patients. We explore a heart team model for care coordination and discuss esthetic approaches for improved cosmetic outcomes in patients undergoing (CIED)‐related procedures or de novo implantation. Methods Patients undergoing CIED surgery for approved indications between June 2015 and June 2022 were identified. Patients were included when surgical care was provided by a collaborative relationship between the primary electrophysiologist and the plastic surgeon. Patient demographics, details of the surgical procedure, information on breast implants, complications, and outcomes related to cosmesis were recorded. Results Twenty‐two female patients were included in this study. The mean age was 50.2 ± 18.2 years. The mean follow‐up duration was 2.2 ± 5.5 months. The top two indications for the procedure included CIED generator change ( n = 9, 41%) and implantable cardioverter‐defibrillator (ICD) implantation ( n = 7, 32%). The most common reasons for involving plastic surgery in the procedure included surgery near breast implants ( n = 10, 45%) and device displacement or discomfort ( n = 8, 36%). CIED pocket position was prepectoral in 10 cases (45%), subpectoral in 11 patients (50%), and intramuscular in one patient (4.5%). The majority of the patients (20, 91%) had cosmetically acceptable results postprocedure. One patient (4.5%) had breast asymmetry on the CIED side, and another continued to have skin erosion over the CIED and leads. Conclusion A heart team approach incorporating the expertize of cardiac electrophysiology and plastic surgery is essential for providing optimal care for patients with breast implants and patients requesting esthetic appeal.
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis
Kleinstern, Geffen , Boddicker, Nicholas , O’Brien, Daniel R. , Allmer, Cristine, Rabe, Kari G. , Waller, Rosalie G. , Yan, Huihuang , Ma, Tao , Call, Timothy G. , Bruins, Laura A., Brown, Sochilt , Campos, Cecília Bonolo de , Hanson, Curtis A. , Leis, José F., Ding, Wei , Vachon, Celine M. , Oakes, Christopher C. , Parker, Alexander S. , Brander, Danielle M. , Weinberg, J. Brice , Furman, Richard R. , Shanafelt, Tait D. , Griffin, R. L. , Boddicker, Nicholas J , Waller, Rosalie G , Bruins, Laura, Bonolo de Campos, Cecilia, Vachon, Celine M. , Kay, Neil E , Cerhan, James R , Parikh, Sameer A , Braggio, Esteban , Slager, Susan L , Chaffee, Kari G. , Ding, Wei , Shanafelt, Tait D , Griffin, Rosalie , Norman, Aaron D. , Kay, Neil E. , Cerhan, James R. , Parikh, Sameer A. , Braggio, Esteban , Slager, Susan L.

Blood Advances | February 15, 2024 | Volume: 8 | Issue: 9 | Pages: 2118-2129

10.1182/bloodadvances.2023012242 | PMID 38359367 Get It

Abstract High-count monoclonal B-cell lymphocytosis (HCMBL) is a precursor condition to chronic lymphocytic leukemia (CLL). We have shown that among individuals with HCMBL, the CLL-International Prognostic Index (CLL-IPI) is prognostic for time-to-first therapy (TTFT). Little is known about the prognostic impact of somatically mutated genes among individuals with HCMBL. We sequenced DNA from 371 individuals with HCMBL using a targeted sequencing panel of 59 recurrently mutated genes in CLL to identify high-impact mutations. We compared the sequencing results with that of our treatment-naïve CLL cohort (N = 855) and used Cox regression to estimate hazard ratios and 95% confidence intervals (CIs) for associations with TTFT. The frequencies of any mutated genes were lower in HCMBL (52%) than CLL (70%). At 10 years, 37% of individuals with HCMBL with any mutated gene had progressed requiring treatment compared with 10% among individuals with HCMBL with no mutations; this led to 5.4-fold shorter TTFT (95% CI, 2.6-11.0) among HCMBL with any mutated gene vs none, independent of CLL-IPI. When considering individuals with low risk of progression according to CLL-IPI, those with HCMBL with any mutations had 4.3-fold shorter TTFT (95% CI, 1.6-11.8) vs those with none. Finally, when considering both CLL-IPI and any mutated gene status, we observed individuals with HCMBL who were high risk for both prognostic factors had worse prognosis than patients with low-risk CLL (ie, 5-year progression rate of 32% vs 21%, respectively). Among HCMBL, the frequency of somatically mutated genes at diagnosis is lower than that of CLL. Accounting for both the number of mutated genes and CLL-IPI can identify individuals with HCMBL with more aggressive clinical course.
Don’t let the genie out of the bottle!
Kumar, Shaji

Blood | February 15, 2024 | Volume: 143 | Issue: 7 | Pages: 564-566

10.1182/blood.2023023293 | PMID 38358852 Get It